former CEO of BlueRock Therapeutics, based in Massachusetts
Ensoma, Inc. is an in vivo Gene Therapy founded in 2019.
Stylus Medicine is on a quest to create disease-treating agents for the next generation based on the groundbreaking work of its founders.
A biotechnology company developing engineered cell therapies for treating diseases in neurology, cardiology and autoimmunity.